About 2,190 results
Open links in new tab
PipelineReview.com. Biopharmaceutical News & Clinical Trials
Zydus launches Ujvira (Trastuzumab Emtansine), a ... - Pipelinereview
Vaxxinity Announces First Subjects Dosed in Phase 1
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug …
Zydus Lifesciences initiates Phase II clinical trial of ZYIL1, a novel ...
Boehringer Ingelheim Begins Clinical Development of First-In-Class ...
Zydus receives Phase I clinical trial permission for ZYBK2 from DCGI
Vaxcyte Announces FDA Clearance of Investigational New
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI …
CureVac Announces Positive Phase 2 Interim Data from COVID-19 …